In the current study, we found that FA relived hepatic fibrosis by, at least partly, directly binding to and acting as a PTP1B antagonist, which further confirmed our hypothesis that the binding ability between FA and AMPK was weaker than that between FA with PTP1B (Figure 5). The gene discussed is PTPN1; the disease is Hepatic fibrosis.